Unilever Considers $4 Billion Bid for Supplement Maker Thorne

Unilever is evaluating a potential bid for Thorne, a supplement manufacturer valued at $4 billion, as it seeks to strengthen its health and wellness portfolio. The maker of Dove soap is pivoting toward this sector after spinning off its food business. The company aims to secure a stronger position in the vitamin and supplement market through the acquisition of Thorne. Thorne, a brand known for high-quality health supplements, could significantly enhance Unilever's existing range of health products. This move is seen as part of Unilever's investments in the health and wellness segment in recent years. The company has previously completed several acquisitions in this area. Unilever's decision to separate its food business has allowed it to focus on more profitable and high-growth areas such as health, beauty, and personal care. Acquiring Thorne would support this strategy and expand Unilever's health portfolio. Although no formal offer has been made yet, sources indicate that Unilever has initiated discussions with Thorne. If the deal goes through, it could accelerate Unilever's growth in the health and wellness segment. However, such acquisitions are subject to regulatory approvals, so the process may take time to complete. This is not investment advice.